COVID-19 Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2020-09-02
Clinical Trial Update: Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection [Phase 4]
A Phase 4 trial evaluating dexmedetomidine for light to moderate sedation in palliative COVID-19 patients has been withdrawn.